| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| imfinzi durvalumab biggest clinical trial | 0.45 | 0.8 | 2004 | 70 | 41 |
| imfinzi | 1.48 | 1 | 1184 | 49 | 7 |
| durvalumab | 1.01 | 0.1 | 2853 | 35 | 10 |
| biggest | 0.92 | 0.7 | 6083 | 97 | 7 |
| clinical | 0.9 | 0.4 | 1310 | 51 | 8 |
| trial | 1.93 | 1 | 4182 | 39 | 5 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| imfinzi durvalumab biggest clinical trial | 0.99 | 0.2 | 7036 | 61 |
| imfinzi durvalumab biggest cost | 0.21 | 0.9 | 9911 | 87 |
| imfinzi durvalumab biggest comparison | 1.34 | 0.7 | 3287 | 75 |
| imfinzi durvalumab biggest collaboration | 1.14 | 1 | 3052 | 52 |
| imfinzi durvalumab biggest challenge | 1.1 | 0.5 | 5703 | 24 |
| imfinzi durvalumab biggest company | 0.86 | 0.9 | 8396 | 66 |
| imfinzi durvalumab biggest controversy | 0.77 | 1 | 2154 | 86 |
| imfinzi durvalumab biggest competitor in cost | 0.45 | 0.4 | 4977 | 54 |
| imfinzi durvalumab biggest competitor | 1.36 | 0.4 | 8419 | 9 |
| imfinzi durvalumab biggest customer | 0.28 | 0.2 | 5081 | 11 |
| imfinzi durvalumab biggest commercial | 1.64 | 1 | 3957 | 53 |
| durvalumab imfinzi package insert | 0.23 | 0.3 | 4677 | 96 |
| imfinzi biggest competitor in clinical trials | 1.04 | 0.6 | 8433 | 41 |
| pacific clinical trial durvalumab | 1.11 | 0.3 | 5331 | 7 |
| j code for imfinzi durvalumab | 1.28 | 0.8 | 669 | 48 |
| cpt code for durvalumab imfinzi | 1.42 | 0.3 | 2159 | 33 |
| imjudo tremelimumab + imfinzi durvalumab | 1.04 | 0.1 | 3769 | 50 |
| imfinzi durvalumab side effects | 1.95 | 0.8 | 4017 | 83 |
| pacific trial durvalumab update | 0.93 | 0.3 | 5379 | 2 |
| durvalumab + tremelimumab | 0.26 | 0.8 | 4443 | 91 |
